USPTO serial 99531464
Serial No. 99531464
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CANTOR, JILLIAN REDDING
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with Serial No. 99531464?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Winston Salem, NC, US
Winston Salem, NC, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen K. Won
Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.One Financial CenterBoston, MA 02111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Bioengineered human cells and biological tissues, namely, kidney cells and tissue, for scientific and medical research uses; Biological cell and tissue cultures, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Pharmaceutical and biologic preparations for treating and managing chronic kidney disease; Pharmaceutical and biologic preparations for preventing, treating, and delaying diseases, disorders, and conditions affecting the kidneys; Therapeutic agents for promoting kidney function and treating kidney structure diseases; Biological compounds for medical use, namely, formulated selected renal cells delivered into patient's damaged kidney for repairing damaged tissue and restoring kidney function; Biologics in the nature of an autologous homologous cell mixture for renal therapeutic purposes; Medicaments for personalized cell therapy used in renal diseases, disorders, and conditions; Pharmaceutical and biologic preparations for preserving kidney function to prevent kidney failure | ACTIVE | — |
| 010 | Drug administration apparatus kits consisting primarily of medical syringes, catheters, and injection needles; Medical apparatus, namely, injection devices for administering drugs | ACTIVE | — |
| 040 | Custom manufacturing of engineered cell and tissue, personalized cell therapy preparations, and biologic preparations for renal diseases, disorders, and conditions | ACTIVE | — |
| 042 | providing scientific and medical research information in the fields of engineering and regenerating human cells and tissue, conditions, disorders and diseases affecting kidneys, renal function; providing temporary use of non-downloadable computer software for tracking packages, shipments, and inventory over computer networks, intranets and the internet; Scientific and medical research and development in the fields of engineering and regenerating human cells and tissue, conditions, disorders and diseases affecting kidneys, renal function, cell therapy, regenerative medicine, and personalized medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ProKidney IPCo, LLC
- Other trademarks owned by ProKidney IPCo, LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 6, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 30, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 9, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 3, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 9, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 9, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 10, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 5, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 5, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 5, 2025 | NWAP | NEW APPLICATION ENTERED | — |